Cited by 32Schizophrenia research and treatmentTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Understanding and Predicting Variability in Response to Treatment in Psychotic Disorders: In Vivo Findings

Open access
Jauhar, Sameer, Howes, Oliver D.·2019·Clinical Pharmacology & Therapeutics

Abstract

O.D.H. has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Astra-Zeneca, Autifony, BMS, Eli Lilly, Heptares, Janssen, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither O.D.H. nor his family have been employed by or have holdings/a financial stake in any biomedical company. S.J. reports no conflict of interest.

Integrity signals

Registry

Crossref · 10.1002/cpt.1357

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jauhar, S., & Howes, O. D.
Affiliations
King's College London (GB)
Corresponding author
Howes, Oliver D.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2019-03-18
Volume
105
Issue
5
Pages
1079-1081
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2921486418
Cited by
32
References
5
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 24 · 2020: 1 · 2019: 1
FWCI
5.37
Type
journal article
Language
en
Open access
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
Funders
  • Medical Research Council (MC‐A656‐5QD30)
  • Brain and Behavior Research Foundation
  • Wellcome Trust (094849/Z/10/Z)
  • King’s College London
  • Royal College of Physicians of Edinburgh
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
treatment response variability, psychosis, schizophrenia, antipsychotic drugs, in vivo pharmacology, treatment response prediction, drug response variability
MeSH terms
Dopamine, Drug Resistance, Humans, Prognosis, Psychotic Disorders, Antipsychotic Agents, Treatment Outcome, Outcome Assessment, Health Care, Neurotransmitter Agents, Biomarkers, Pharmacological, Medication Therapy Management, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review